SHS Capital has acquired a majority stake in Ackermann Instrumente GmbH, aiming to establish a leading MedTech group by leveraging Ackermann's global reach and strong product offerings.

Information on the Target

SHS Capital has signed a binding agreement to acquire a majority stake in Ackermann Instrumente GmbH, a prominent German manufacturer of high-quality surgical instruments. The company specializes in various surgical fields including endoscopy, implantology, and general surgery, and boasts a global customer base. The transaction is expected to conclude shortly, facilitating a succession strategy for the family-run business.

Ackermann Instrumente GmbH, headquartered close to Tuttlingen, operates a vertically integrated production model, ensuring exceptional product quality and cost efficiency. With extensive experience in regulatory compliance and operational flexibility, Ackermann has built a reputation as a reliable partner for both medical professionals and MedTech companies. The firm has enjoyed steady revenue growth and boasts a diverse, expanding customer network, making it well-positioned to leverage the global shift towards minimally invasive surgical procedures, particularly in emerging markets.

Industry Overview in Germany

The MedTech industry in Germany is undergoing significant consolidation driven by the evolving Medical Device Regulation (MDR) and the ongoing need for innovation and globalization. As one of the largest healthcare sectors in Europe, the German